top of page
i4 Teams
1/5
Keith Abbey
Andrew Hoang
Tyler Lee
Sasank Sivadanam
Alex Sprague
Helen Tran
Of the 320,000 cases of colectomy, a common colon reattachment surgical procedure to treat colon cancer performed yearly, about 18% leak following the surgery, causing life-threatening complications and repeat procedures with high mortality rates. The onset of these post-operative anastomotic leaks (AL) is still unknown; visible symptoms are often detected 5 to 7 days after surgery, but leaks may occur earlier. EnteroFlux proposes a continuous optical sensing system that notifies healthcare providers of an AL as early as 12 hours after the surgery while being noninvasive. Our device minimizes the likelihood of complications and improves patient outcomes.
EnteroFlux
Zoe Levine
Alexandra Maycock
Ali Myers
Claire Wiebking
Lauren Reynolds
McKinna Estridge
Tucker Bennett
Monday Morning Medical is developing a test strip that analyzes biomarkers for wound healing in an effort to provide concrete evidence of wound progression to the clinician. The test strip uses ELISA technology to analyze the concentration of MMP-2, a biomarker that increases to a a concentration of 0.22 µg/mL and then decreases in a wound that is healing normally. This solution will help clinicians determine when to remove surgical drains in order to limit infection and seroma of the wound.
Monday
Morning
Medical
Evan Bartle
Avery Morris
Emilie Norwood
Christopher Petersen
Abby Sweitzer
JT Thress
Kaitlynn Whimpenny
Handm-aid is developing a cleaning device for laparoscopic instruments which ensures the removal of biofilm after a surgical procedure and before sterilization. This will lead to a reduced risk of infection from following procedures using laparoscopic instruments that have biofilm remaining after the current cleaning process.
Handm-aid
Will McLain
Hasan Dheyaa
Tian Wang
Varad Gurude
15% of nasogastric tubes are incorrectly inserted through the trachea instead of through the esophagus, of which 1.2% result in pneumothorax or collapsed lung. Existing technologies provide verification of tube placement after the procedure is complete; however, they do little to prevent the misplacement itself. V&P’s goal is to create an external device that indicates nasogastric tube placement in real-time by using the CO2 differential between the esophageal and tracheal pathways to indicate the nasogastric tube’s placement. Unlike existing solutions, our solution indicates tube placement in real-time, allowing clinicians to react before tube-induced damage occurs.
Captio Innovations
bottom of page